Among women with SMO, oxytocin was given in 3862 women (93.5 %) for prevention of postpartum hemorrhage, and only 97 of 134 women with severe PPH (72.4 %) received oxytocin as treatment. This evidence concerns the gene OXT and pulmonary arterial hypertension.